The Sydney Children's Hospital experience with the oral iron chelator deferiprone (L1)
- 28 November 2000
- journal article
- research article
- Published by Elsevier in Transfusion Science
- Vol. 23 (3) , 239-240
- https://doi.org/10.1016/s0955-3886(00)00092-8
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Long-Term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia MajorNew England Journal of Medicine, 1998
- Results of long‐term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron ChelatorsBritish Journal of Haematology, 1995
- Iron-Chelation Therapy with Oral Deferiprone in Patients with Thalassemia MajorNew England Journal of Medicine, 1995